Contec Medical Systems Co Ltd Net Assets
Contec Medical Systems Co Ltd net assets. Based on the latest financial reports, Contec Medical Systems Co Ltd (300869) has net assets worth CN¥1.77 Billion CNY (≈ $258.44 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.79 Billion ≈ $408.39 Million USD) and total liabilities (CN¥1.02 Billion ≈ $149.95 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Contec Medical Systems Co Ltd (300869) net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.77 Billion |
| % of Total Assets | 63.28% |
| Annual Growth Rate | 23.45% |
| 5-Year Change | 18.4% |
| 10-Year Change | 533.3% |
| Growth Volatility | 45.54 |
Net Assets of Contec Medical Systems Co Ltd (2013–2024)
Net assets of Contec Medical Systems Co Ltd from 2013 to 2024. This chart illustrates how Contec Medical Systems Co Ltd's net assets have evolved over time, based on quarterly financial data. See 300869 equity to assets ratio to measure how much of total assets are equity-financed.
Annual Net Assets for Contec Medical Systems Co Ltd (2013–2024)
The table below shows the annual net assets of Contec Medical Systems Co Ltd from 2013 to 2024. For live market cap and overall valuation, see how much is Contec Medical Systems Co Ltd worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.86 Billion ≈ $271.80 Million |
-9.16% |
| 2023-12-31 | CN¥2.04 Billion ≈ $299.22 Million |
+6.04% |
| 2022-12-31 | CN¥1.93 Billion ≈ $282.18 Million |
+5.95% |
| 2021-12-31 | CN¥1.82 Billion ≈ $266.33 Million |
+16.01% |
| 2020-12-31 | CN¥1.57 Billion ≈ $229.57 Million |
+168.99% |
| 2019-12-31 | CN¥583.23 Million ≈ $85.34 Million |
+14.53% |
| 2018-12-31 | CN¥509.23 Million ≈ $74.52 Million |
+14.05% |
| 2017-12-31 | CN¥446.51 Million ≈ $65.34 Million |
+20.35% |
| 2016-12-31 | CN¥371.02 Million ≈ $54.29 Million |
+26.50% |
| 2015-12-31 | CN¥293.29 Million ≈ $42.92 Million |
+28.08% |
| 2014-12-31 | CN¥229.00 Million ≈ $33.51 Million |
+25.13% |
| 2013-12-31 | CN¥183.01 Million ≈ $26.78 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Contec Medical Systems Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 839.1% over the analyzed period, indicating profitable operations and earnings retention.
Contec Medical Systems Co Ltd Net Assets Breakdown (December 2024)
Contec Medical Systems Co Ltd net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥892.41 Million | 48.05% |
| Common Stock | CN¥401.80 Million | 21.63% |
| Other Comprehensive Income | CN¥218.39 Million | 11.76% |
| Other Components | CN¥344.82 Million | 18.56% |
| Total Equity | CN¥1.86 Billion | 100.00% |
Contec Medical Systems Co Ltd Competitors by Market Cap
The table below lists competitors of Contec Medical Systems Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ADENTRA INC.
F:UQ0
|
$586.29 Million |
|
Guangzhou Grandbuy Co Ltd
SHE:002187
|
$586.66 Million |
|
Shaanxi Construction Machinery Co Ltd
SHG:600984
|
$586.78 Million |
|
Suzhou Longway Electronic Machinery Co. Ltd. A
SHE:301202
|
$586.81 Million |
|
ENCE Energía y Celulosa S.A
MC:ENC
|
$586.18 Million |
|
Sygnity SA
WAR:SGN
|
$585.89 Million |
|
Mercuries & Associates Holding Ltd
TW:2905
|
$585.70 Million |
|
TOMTOM N.V.ADRS 1/2 EO-20
F:OEMB
|
$585.53 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Contec Medical Systems Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,044,796,689 to 1,857,415,749, a change of -187,380,940 (-9.2%).
- Net loss of 77,902,564 reduced equity.
- Dividend payments of 127,716,768 reduced retained earnings.
- Other comprehensive income increased equity by 11,062,148.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-77.90 Million | -4.19% |
| Dividends Paid | CN¥127.72 Million | -6.88% |
| Other Comprehensive Income | CN¥11.06 Million | +0.6% |
| Other Changes | CN¥7.18 Million | +0.39% |
| Total Change | CN¥- | -9.16% |
Book Value vs Market Value Analysis
This analysis compares Contec Medical Systems Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.46x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.23x to 2.46x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥1.91 | CN¥9.97 | x |
| 2014-12-31 | CN¥2.27 | CN¥9.97 | x |
| 2015-12-31 | CN¥0.86 | CN¥9.97 | x |
| 2016-12-31 | CN¥1.08 | CN¥9.97 | x |
| 2017-12-31 | CN¥1.22 | CN¥9.97 | x |
| 2018-12-31 | CN¥1.40 | CN¥9.97 | x |
| 2019-12-31 | CN¥1.45 | CN¥9.97 | x |
| 2020-12-31 | CN¥3.90 | CN¥9.97 | x |
| 2021-12-31 | CN¥4.53 | CN¥9.97 | x |
| 2022-12-31 | CN¥4.72 | CN¥9.97 | x |
| 2023-12-31 | CN¥4.93 | CN¥9.97 | x |
| 2024-12-31 | CN¥4.05 | CN¥9.97 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Contec Medical Systems Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -4.19%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -16.24%
- • Asset Turnover: 0.18x
- • Equity Multiplier: 1.47x
- Recent ROE (-4.19%) is below the historical average (18.06%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 29.39% | 25.18% | 0.78x | 1.49x | CN¥35.49 Million |
| 2014 | 23.78% | 21.60% | 0.83x | 1.33x | CN¥31.56 Million |
| 2015 | 20.98% | 21.63% | 0.67x | 1.44x | CN¥32.20 Million |
| 2016 | 27.89% | 23.41% | 0.89x | 1.33x | CN¥66.39 Million |
| 2017 | 17.26% | 19.37% | 0.72x | 1.24x | CN¥32.41 Million |
| 2018 | 12.18% | 17.10% | 0.63x | 1.13x | CN¥11.11 Million |
| 2019 | 12.65% | 19.05% | 0.57x | 1.16x | CN¥15.46 Million |
| 2020 | 39.10% | 43.78% | 0.67x | 1.34x | CN¥456.51 Million |
| 2021 | 19.36% | 38.78% | 0.33x | 1.53x | CN¥170.35 Million |
| 2022 | 10.17% | 27.55% | 0.19x | 1.94x | CN¥3.37 Million |
| 2023 | 8.11% | 22.19% | 0.23x | 1.57x | CN¥-38.71 Million |
| 2024 | -4.19% | -16.24% | 0.18x | 1.47x | CN¥-263.64 Million |
Industry Comparison
This section compares Contec Medical Systems Co Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,872,446,566
- Average return on equity (ROE) among peers: 19.27%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Contec Medical Systems Co Ltd (300869) | CN¥1.77 Billion | 29.39% | 0.58x | $586.20 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $2.08 Billion | 10.47% | 0.31x | $387.62 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $482.51 Million | 20.84% | 0.32x | $4.19 Billion |
| Double Medical Technology Inc (002901) | $274.36 Million | 50.77% | 0.99x | $2.51 Billion |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $115.39 Million | 30.85% | 0.16x | $490.64 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $3.36 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $810.45 Million |
| Edan Instruments Inc (300206) | $1.16 Billion | 1.16% | 0.17x | $993.28 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $354.32 Million | 9.53% | 0.12x | $483.51 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $159.72 Million | 34.06% | 0.62x | $468.88 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $1.54 Billion |
About Contec Medical Systems Co Ltd
Contec Medical Systems Co.,Ltd engages in the research and development, production, and sale of medical diagnosis and monitoring equipment in China and internationally. The company offers electronic sphygmomanometers, ambulatory blood pressure monitors, pulse oximeters, patient monitors, stethoscopes, simulators, multi-parameter vital signs monitors, central monitoring systems, electrocardiograph… Read more